Leucid Bio Ltd
Private Limited Company · Cambridge
ActiveUnited KingdomIncorporated 2014Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2016-11-30
IXBRL · 48 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2016-11-30
IXBRL · 48 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2015-12-01 to 2016-11-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 24
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0038_09331486_20161130
- Source archive
- Accounts_Monthly_Data-January2017.zip
Accounts to 2015-11-30
IXBRL · 36 source facts · 9 selected values
Not assessedlegacy record
Accounts to 2015-11-30
IXBRL · 36 source facts · 9 selected values
Not assessed
legacy record
- Reporting period
- 2014-11-27 to 2015-11-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 12
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0030_09331486_20151130
- Source archive
- Accounts_Monthly_Data-May2016.zip
Registered details
09331486- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2014-11-27
- Jurisdiction
- —
- Registered office
- BUILDING 1000, BEACH DRIVE, CAMBRIDGE, CB25 9PD, ENGLAND
Classification
1 SIC codes23006
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
1 SH01-derived rounds2025-02-13
£7,299,161 raised
£19,324,284 estimated post-money
Research and innovation
1 matched grantsNext generation molecular imaging and therapy with radionuclidesEPSRC · Research Grant · 2019-09-30 – 2025-03-30 · with 29 other participants£6,437,105whole project
Next generation molecular imaging and therapy with radionuclides
EPSRC · Research Grant · 2019-09-30 – 2025-03-30 · with 29 other participants
£6,437,105
whole project
King'S College LondonleadAdvanced Accelerator ApplicationsAltra Cyclotron Services LtdAstrazenecaAstraZenecaBicycle Tx LtdCell Therapy CatapultClarity PharmaceuticalsCytiva EuropeEuropean CommissionGe Healthcare LimitedGlaxoSmithKline (GSK)GskImaging Equipment LtdInnoMedicaLeucid Bio LtdLevco PharmaceuticalsLIFNano TherapeuticsLipomedix Pharmaceuticals LtdMcMaster UniversityNanoMabNational Nuclear LaboratoryNational Physical LaboratoryRheacellTheragnostics LtdUniversity Of BirminghamUniversity of BristolUniversity of Hong KongUniversity of SurreyViewpoint Molecular Targeting